4 Midcap Strong Promoter and Institutional Holding Stocks to Watch for Future Multibagger Potential: Ashok Leyland, SRF, Oberoi Realty and Ajanta Pharma
- October 30, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Ashok Leyland Rs 145. SRF Rs 2,358.60. Oberoi Realty Rs 1,640. Ajanta Pharma Rs 3,459.70. Market caps from Rs 43,549 crore to Rs 86,320 crore. Data as of 29 Oct 2026.
Quick Answer
Ashok Leyland, SRF, Oberoi Realty and Ajanta Pharma are the 4 picks in this strong promoter and institutional holding stocks watchlist, with market caps between Rs 43,549 crore and Rs 86,320 crore. Ashok Leyland stands out for the highest return on equity at 24.37%, while SRF offers the strongest latest-quarter profit growth at 75.53%. PE ratios run from 23.15 to 38.37, so compare each one with its industry PE before investing. All figures are as of 29 October 2026.
Strong promoter and institutional holding stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Ashok Leyland, SRF, Oberoi Realty and Ajanta Pharma meet that test, with market caps from Rs 43,549 crore to Rs 86,320 crore and Ashok Leyland offering the highest return on equity at 24.37%. Each of these companies has a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a promoter holding of at least 50 per cent and a combined FII and DII holding of at least 20 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation between Rs 30,000 crore and Rs 1,00,000 crore and a promoter holding of at least 50 per cent and a combined FII and DII holding of at least 20 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap between Rs 30,000 crore and Rs 1 lakh crore. Investors screening strong promoter and institutional holding stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 29 October 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Strong Promoter and Institutional Holding Stocks and Why Do They Attract Multibagger Interest?
Strong promoter and institutional holding stocks are shares of mid sized companies in which the promoters own at least half of the business and foreign and domestic funds together own a fifth or more, so owners and large funds back the same company. The four here cover commercial vehicles, specialty chemicals, real estate and pharmaceuticals.
When founders keep a large stake and professional funds also hold a big share, the interests of both groups line up, and growth in profit gives each of them a reason to stay invested. Within strong promoter and institutional holding stocks, the four companies show rising profit. For strong promoter and institutional holding stocks, both FY26 and the latest quarter showed growth. Whichever way you read strong promoter and institutional holding stocks, the common thread is rising profit backed by complete financial data. For strong promoter and institutional holding stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of strong promoter and institutional holding stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for strong promoter and institutional holding stocks before you decide.
Strong Promoter and Institutional Holding Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book
Prices are closing prices as of 29 October 2026. Ashok Leyland combines the lowest PE of the group, 23.15, with the highest return on equity, 24.37%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Price to Book | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Ashok Leyland | 145 | 86,320 | 23.15 | 23.62 | 24.37% | 6.06 | 134.21 to 215.42 |
| SRF | 2,358.60 | 74,824 | 34.61 | 36.15 | 13.07% | 5.33 | 2,310.00 to 3,210.00 |
| Oberoi Realty | 1,640 | 61,662 | 23.45 | 31.94 | 13.99% | 3.44 | 1,391.20 to 1,986.10 |
| Ajanta Pharma | 3,459.70 | 43,549 | 38.37 | 36.35 | 23.33% | 9.62 | 2,380.20 to 3,796.00 |
Ashok Leyland: Return on Equity of 24.37%
Ashok Leyland makes trucks, buses and defence vehicles and is among the largest commercial vehicle makers in India. It reported FY26 revenue of Rs 56,946.90 crore, up 16.47% year on year, and net profit of Rs 3,720.98 crore, up 10.00%. Revenue has compounded at 21.28% a year since FY22. Operating margin was 19.17% in FY26.
In the June 2026 quarter, revenue rose 12.29% to Rs 13,258.24 crore and net profit grew 1.53% to Rs 667.77 crore. The share price has gained 106.37% over five years. Domestic institutions raised their holding from 13.61% in July 2025 to 15.76% in June 2026. The stock trades at a PE of 23.15 against an industry PE of 23.62, below the sector average, with a return on equity of 24.37%. The dividend yield is 2.38%.
SRF: Quarterly Profit Up 75.53%
SRF operates in specialty chemicals, packaging films and technical textiles, and its chemicals business is a key earnings driver. It reported FY26 revenue of Rs 15,893.57 crore, up 7.20% year on year, and net profit of Rs 1,835.18 crore, up 46.72%. Revenue has compounded at 6.08% a year since FY22. Operating margin was 21.74% in FY26. The debt-to-equity ratio is 0.36.
The stock trades at a PE of 34.61 against an industry PE of 36.15, below the sector average, with a return on equity of 13.07%. In the June 2026 quarter, revenue rose 31.69% to Rs 5,067.17 crore and net profit grew 75.53% to Rs 758.87 crore. Domestic institutions raised their holding from 18.85% in June 2025 to 22.44% in June 2026.
Oberoi Realty: 24.40% Profit CAGR Since FY22
Oberoi Realty develops premium residential, office, retail and hotel projects, mainly in Mumbai. It reported FY26 revenue of Rs 6,304.27 crore, up 15.16% year on year, and net profit of Rs 2,507.43 crore, up 12.67%. Net profit has compounded at 24.40% a year since FY22, while revenue has grown 23.02% a year. Operating margin was 60.69% in FY26. The debt-to-equity ratio is 0.16.
In the June 2026 quarter, revenue rose 26.79% to Rs 1,361.69 crore and net profit grew 29.02% to Rs 543.51 crore. The share price has gained 93.04% over five years. Domestic institutions raised their holding from 10.80% in June 2025 to 14.83% in June 2026. The stock trades at a PE of 23.45 against an industry PE of 31.94, below the sector average, with a return on equity of 13.99%.
Ajanta Pharma: Return on Equity of 23.33%
Ajanta Pharma sells branded generics in ophthalmology, dermatology, cardiology and pain management in India, Africa and Asia. It reported FY26 revenue of Rs 5,624.93 crore, up 18.60% year on year, and net profit of Rs 1,056 crore, up 14.73%. Net profit has compounded at 10.33% a year since FY22, while revenue has grown 12.94% a year. Operating margin was 28.74% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.
The stock trades at a PE of 38.37 against an industry PE of 36.35, with a return on equity of 23.33%. In the June 2026 quarter, revenue rose 27.68% to Rs 1,696.86 crore and net profit grew 30.89% to Rs 334.22 crore. The share price has gained 125.31% over five years and 35.42% over the past year. Domestic institutions raised their holding from 17.90% in September 2025 to 21.94% in September 2026.
Strong Promoter and Institutional Holding Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these strong promoter and institutional holding stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | Latest Quarter Revenue Growth | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Ashok Leyland | 56,946.90 | 3,720.98 | 16.47% | 21.28% | 12.29% | 20.01% |
| SRF | 15,893.57 | 1,835.18 | 7.20% | 6.08% | 31.69% | 25.73% |
| Oberoi Realty | 6,304.27 | 2,507.43 | 15.16% | 23.02% | 26.79% | 61.42% |
| Ajanta Pharma | 5,624.93 | 1,056 | 18.60% | 12.94% | 27.68% | 30.41% |
Check the Univest Screener for live data on these strong promoter and institutional holding stocks
Institutional Holding in Ashok Leyland, SRF, Oberoi Realty and Ajanta Pharma
Institutional holding shows who is backing these strong promoter and institutional holding stocks alongside the promoter. The table uses the latest reported quarter for each. SRF has the deepest institutional backing, with FII and DII together holding 37.89% as of June 2026. Domestic institutions increased their holding over the past year in Ashok Leyland (from 13.61% to 15.76%), SRF (from 18.85% to 22.44%), Oberoi Realty (from 10.80% to 14.83%) and Ajanta Pharma (from 17.90% to 21.94%).
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Ashok Leyland | 51.51% | 20.68% | 15.76% | 12.05% | June 2026 |
| SRF | 50.26% | 15.45% | 22.44% | 11.85% | June 2026 |
| Oberoi Realty | 67.70% | 15.11% | 14.83% | 2.36% | June 2026 |
| Ajanta Pharma | 63.47% | 7.63% | 21.94% | 6.96% | September 2026 |
Risks to Weigh in Strong Promoter and Institutional Holding Stocks
Being careful with strong promoter and institutional holding stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Ajanta Pharma trades at a PE of 38.37 against an industry PE of 36.35, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Strong Promoter and Institutional Holding Stocks
Picking from strong promoter and institutional holding stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (23.62 to 36.35) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Ashok Leyland, SRF, Oberoi Realty and Ajanta Pharma live prices.
Conclusion
Among strong promoter and institutional holding stocks, Ashok Leyland stands out for the highest return on equity at 24.37%, SRF for the strongest latest-quarter profit growth at 75.53%, Oberoi Realty for the fastest profit growth, 24.40% a year since FY22 and Ajanta Pharma for the biggest five-year price gain at 125.31%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing strong promoter and institutional holding stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Strong Promoter and Institutional Holding Stocks to Watch
Which are the best strong promoter and institutional holding stocks to watch for multibagger potential?
Ans. Ashok Leyland, SRF, Oberoi Realty and Ajanta Pharma are the 4 names this list highlights, with market caps of Rs 86,320 crore, Rs 74,824 crore, Rs 61,662 crore and Rs 43,549 crore respectively. Ashok Leyland is notable for the highest return on equity at 24.37%. SRF stands out for the strongest latest-quarter profit growth at 75.53%. Oberoi Realty offers the fastest profit growth, 24.40% a year since FY22. Ajanta Pharma brings the biggest five-year price gain at 125.31%. These are watchlist names for strong promoter and institutional holding stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Ashok Leyland a good stock for long-term investors?
Ans. Ashok Leyland has a return on equity of 24.37%, a PE of 23.15 against an industry PE of 23.62 and a market cap of Rs 86,320 crore. FY26 revenue rose 16.47%, and June 2026 quarter net profit grew 1.53%. Long-term returns in strong promoter and institutional holding stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Oberoi Realty become a multibagger from here?
Ans. Oberoi Realty has already gained 93.04% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in strong promoter and institutional holding stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 24.40% a year since FY22, and FY26 revenue rose 15.16%. At a PE of 23.45 against an industry PE of 31.94, valuation should be checked against that growth before investing.
What is the market cap of Ashok Leyland, SRF, Oberoi Realty and Ajanta Pharma?
Ans. As of 29 October 2026, Ashok Leyland has a market cap of Rs 86,320 crore, SRF has a market cap of Rs 74,824 crore, Oberoi Realty has a market cap of Rs 61,662 crore and Ajanta Pharma has a market cap of Rs 43,549 crore. All of them qualify as midcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on strong promoter and institutional holding stocks.
What are the risks of investing in strong promoter and institutional holding stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Ajanta Pharma trades at a PE of 38.37 against an industry PE of 36.35, so earnings growth needs to hold up.
Is Ashok Leyland trading below its industry PE?
Ans. Ashok Leyland trades at a PE of 23.15 against an industry PE of 23.62. A lower PE means investors pay less for each rupee of earnings, but it should be read with growth (FY26 revenue rose 16.47% and June 2026 quarter net profit grew 1.53%) and balance sheet strength before drawing a conclusion.
How much do institutions hold in Ashok Leyland, SRF, Oberoi Realty and Ajanta Pharma?
Ans. As of the latest reported quarter, FII and DII together hold 36.44% of Ashok Leyland (20.68% and 15.76%), 37.89% of SRF (15.45% and 22.44%), 29.94% of Oberoi Realty (15.11% and 14.83%) and 29.57% of Ajanta Pharma (7.63% and 21.94%). Rising institutional holding is a useful signal in strong promoter and institutional holding stocks, though it should be read with earnings trends rather than on its own.
